SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 99,000
+4,200 (4.43%)
At close: Apr 1, 2026
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.75 trillion as of April 1, 2026. Its market cap has decreased by -13.01% in one year.
Market Cap
7.75T
Enterprise Value
7.51T
Revenue
706.74B
Ranking
n/a
PE Ratio
29.04
Stock Price
99,000.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.75T, a decrease of -22.05%. That is a compound annual growth rate of -4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 7.42T | -23.92% |
| Dec 30, 2025 | 9.76T | 12.15% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 18.97T |
| Samsung Epis Holdings | 13.21T |
| LigaChem Biosciences | 7.77T |
| HLB Co., Ltd. | 7.08T |
| Peptron | 6.94T |
| Voronoi | 5.76T |
| OliX Pharmaceuticals | 4.05T |
| SK bioscience | 3.39T |